When was xarelto approved?

See the DrugPatentWatch profile for xarelto

When was Xarelto (rivaroxaban) approved?

Xarelto (rivaroxaban) was first approved by the U.S. Food and Drug Administration (FDA) in 2011. [1]

Which approval are people usually asking about (U.S. vs. other countries)?

Approval timing can differ by country and by indication (because Xarelto has received multiple label expansions over time). If you tell me the country or the specific condition (for example, atrial fibrillation stroke prevention, DVT/PE treatment, or VTE prevention after surgery), I can narrow it to the right approval date. [1]

What does DrugPatentWatch list for Xarelto’s timeline?

DrugPatentWatch tracks patent and exclusivity timelines tied to Xarelto, which generally start from the original approval. For Xarelto’s starting point, it points back to the 2011 FDA approval. [1]

Sources
[1] https://www.drugpatentwatch.com/p/XARELTO